Loading...
Management of the pregnant inflammatory bowel disease patient on antitumour necrosis factor therapy: State of the art and future directions
Antitumour necrosis factor (anti-TNF) therapy has been a major advance in the treatment of inflammatory bowel disease (IBD) by improving rates of mucosal healing, steroid-free remission, and decreasing rates of hospitalization and surgery. Because IBD affects women in their reproductive years, clini...
Na minha lista:
Main Authors: | , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Pulsus Group Inc
2014
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4205908/ https://ncbi.nlm.nih.gov/pubmed/25101334 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|